SCREENER COMPARE ANY 2 STOCKS

EARNINGS CALL ARCHIVE 4 CALLS ON FILE

IMDX — Insight Molecular Diagnostics Inc.

NASDAQ

FULL STOCK PAGE →

Q3 2025 Earnings Call Summary

NOV 10, 2025

REVENUE

$260000 -49.8%

NET MARGIN

-4174.6% -2293.9 PTS

EPS

-$0.34 -11.8%

FREE CASH FLOW

-$5.6M +16.2%

No summary has been written for this call yet.